Combined treatment with simvastatin and rapamycin attenuates cardiac allograft rejection through the regulation of T helper 17 and regulatory T cells.
about
Combined treatment with simvastatin and rapamycin attenuates cardiac allograft rejection through the regulation of T helper 17 and regulatory T cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Combined treatment with simvas ...... per 17 and regulatory T cells.
@en
Combined treatment with simvas ...... per 17 and regulatory T cells.
@nl
type
label
Combined treatment with simvas ...... per 17 and regulatory T cells.
@en
Combined treatment with simvas ...... per 17 and regulatory T cells.
@nl
prefLabel
Combined treatment with simvas ...... per 17 and regulatory T cells.
@en
Combined treatment with simvas ...... per 17 and regulatory T cells.
@nl
P2093
P2860
P356
P1476
Combined treatment with simvas ...... per 17 and regulatory T cells.
@en
P2093
Bicheng Fu
Dongyang Zhang
Junbo Chuai
Shulin Jiang
Yingjie Liu
P2860
P304
P356
10.3892/ETM.2017.5635
P50
P577
2017-12-14T00:00:00Z